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Introduction
Human exposure to arsenic (As) compounds can be (1) environmental, primarily due to ingestion of contaminated drinking and cooking water and food (especially seafood and rice); (2) occupational, mainly due to smelting of nonferrous metals, wood combustion, manufacture of glass, etc.; or (3) therapeutic, for example, owing to the recent FDA-and EMA-approved use of arsenic trioxide (As 2 O 3 ) for treating patients with acute promyelocytic leukaemia (APL) (Fowler et al., 2015; Khairul et al., 2017) . Inorganic arsenic (iAs), including arsenite (AsIII) and arsenate (AsV) after its bioconversion to AsIII, is primarily biotransformed in the liver via reduction/oxidation and methylation. Methylation conducted in the presence of cofactor glutathione (GSH) with arsenic (3+) methyltransferase (AS3MT) using Sadenosyl-methionine (SAM) as a substrate generates methylated (monomethylarsonic acid, MMA) and dimethylated (dimethylarsinic acid, DMA) arsenicals as major products that are then eliminated in urine (Cullen, 2014; Fowler et al., 2015) . In comparison, other methyltransferases and non-enzymatic methylation routes have been less investigated (Aposhian et al., 2004; Gardner et al., 2012) . Methylation is a crucial factor that influences As tissue distribution and elimination and, consequently, its adverse health effects (Fowler et al., 2015) . Arsenic is mainly eliminated through urine (iAs, MMA, and DMA) and less so through bile (faeces) (iAs and MMA) (Roggenbeck et al., 2016) . The average reported values of eliminated As metabolites in the urine of populations environmentally exposed to low levels of iAs from water are 20-25% for iAs, 15-25% for MMA, and 40-75% for DMA (Fowler et al., 2015) . Several studies also noted considerable individual and populational variations in metabolite profiles (Vahter, 1999) . The As metabolite pattern in urine is influenced by age, body mass index (BMI), gender, dietary habits (As-rich seafood and rice), behavioural factors (smoking and alcohol consumption), As exposure dosage and duration, and various (patho)physiological conditions such as pregnancy or diseases, especially those of the liver, kidney, and cardiovascular system (Taylor et al., 2017; Tseng, 2009) . Some studies, although with some inconsistencies, have also noted the influence of nutritional status, especially that of selenium (Se), folate (vitamin B9), and other B vitamins (B2, B6, and B12) on As metabolism (Gamble et al., 2006; Gardner et al., 2011; Li et al., 2008; Spratlen et al., 2017; Thomas and Bradham, 2016; Tseng, 2009) .
Selenium is an essential element (Schwarz and Foltz, 1957 ) with multiple physiological roles, mainly as a component of various selenoproteins in the form of the amino acid selenocysteine (Alexander, 2015) . Selenium has been shown to play a complex role in As metabolism, elimination, and toxicity (Falnoga et al., 2014; George et al., 2013; Sun et al., 2014; Zeng et al., 2005) . Elements are mutually antagonistic, and the addition of one increases the elimination of the other. In 2002, seleno-bis(S-glutathionyl) arsinium ion ([(GS) 2 AsSe] -) was isolated and identified as a major metabolite eliminated into the bile of rabbits (Gailer et al., 2002) ; in 2011, it was also detected in human blood (La Porte, 2011) . Because, the transporter of the [(GS) 2 AsSe] -complex, multidrug resistance associated protein 2 (MRP2), was also identified in kidney cells (Carew and Leslie, 2010) , the elimination of this complex through urine was suggested (Skröder Löveborn et al., 2016) . Considerable variations in urine As metabolite profiles observed between different ethnical groups exposed to similar levels of As in drinking water suggest the influence of genetic variations, as has been frequently noted in the last decade (Agusa et al., 2015; Broberg et al., 2015; Hernández and Marcos, 2008) . The AS3MT gene has been widely studied as the key enzyme in As methylation. Studies conducted in populations historically exposed to high levels of As in drinking water identified several noncoding single nucleotide polymorphisms (SNPs) of AS3MT, such as rs7085104, rs3740400, rs3740393, rs3740390, rs11191453, rs10748835, and rs1046778, with minor alleles mostly associated with lower iAs% and MMA% and higher DMA% (Agusa et al., 2015; Broberg et al., 2015; Engström et al., 2011 Hernández and Marcos, 2008) . This consistent association of various SNPs with more efficient iAs methylation could be explained by the strong correlation between these alleles (as estimated by linkage disequilibrium (LD)) in populations. As such, these SNP alleles tend to occur together and are usually inherited as a cluster representing specific nucleotide sequences called haplotypes. By contrast, one coding SNP was associated with less-efficient As methylation (rs11191439). Studies have introduced various clusters of selected SNP alleles associated with more efficient As methylation as 'protective' haplotypes (Agusa et al., 2015 (Agusa et al., , 2009 Broberg et al., 2015; De la Rosa et al., 2017; Engström et al., 2015 Engström et al., , 2011 Engström et al., , 2007 . AS3MT genetic variations may impact enzyme function by affecting their gene expression and/or translation (Engström et al., 2011 . The population frequency of the 'protective' AS3MT haplotype varies in terms of dosage and longterm duration of iAs exposure. In populations with high historic iAs exposure in drinking water (200-1000 µgAs/L; for example, Argentina, Peru, and Chile), observed frequencies of 50-70% indicate genetic adaptations to arsenic-enriched environments (Apata et al., 2017; Eichstaedt et al., 2015; Schlebusch et al., 2015a Schlebusch et al., , 2015b Schlebusch et al., , 2013 . In European populations exposed to low to moderate iAs levels in drinking water (0.01-167 µgAs/L; for example, Slovakia, Hungary, and Romania), the reported frequencies are lower, being 10-14% .
In addition to AS3MT, variations in various other genes may also influence the urine As metabolite pattern. Among them are SNPs in the gene coding for methylene tetrahydrofolate reductase (MTHFR), one of the genes involved in one-carbon metabolism (Gamboa-Loira et al., 2018) , like AS3MT. The one-carbon metabolism is a network of various physiological processes including biosynthesis of methionine, which is a substrate of SAM-a methyl donor for As methylation . MTHFR SNPs were found to be associated with less-efficient arsenic methylation, as reflected by the higher MMA% and/or lower DMA% among populations with moderate to high iAs exposure (Engström et al., 2007; Lindberg et al., 2007) .
Many studies have investigated genes involved in the GSH metabolism; variations in genes of glutathione S-transferases (GSTs) are related to GSH capacity. Variations in the gene of purine nucleoside phosphorylase (PNP) are possibly involved in AsV to AsIII reduction Hernández and Marcos, 2008) and variations in the gene of DNA methyltransferases (DNMT1a and N6AMT1) Chen et al., 2017; De la Rosa et al., 2017; Gardner et al., 2012) and the genes of metallothioneins (MTs) (González-Martínez et al., 2018) . were also found to be associated with the methylation capacity or elimination (or better urine concentrations) of As. Additionally, possible candidate variations in relation to As kinetics could be those in genes coding for aquaporins (AQPs), as AQP3, AQP4, AQP7, AQP9, and AQP10 were shown to be responsible for AsIII uptake (Calatayud and Laparra Llopis, 2015; Calatayud et al., 2012; Mukhopadhyay et al., 2014; Roggenbeck et al., 2016) and in genes involved in elimination of Se through urine, such as indolethylamine Nmethyltransferase (INMT) (Amorós et al., 2018; Kuehnelt et al., 2015; Skröder et al., 2018) , or Se transport and storage, such as selenoprotein P1 (SELENOP) (Burk and Hill, 2005; Mao et al., 2016) .
The evaluation of the population genotype/haplotype frequencies of SNPs associated with more-or less-efficient As metabolism in combination with Se status is essential for the health risks assessment of arsenic exposure, especially in the case of major unpredicted environmental As contamination, and for the individual estimation of As 2 O 3 effectiveness during acute promyelocytic leukaemia therapy. However, it should be noted that the magnitude of the genetic influences on arsenic metabolism is basically unknown. It may depend on various factors like the degree of As exposure pregnancy status (Gardner et al., 2012) , nutritional status (Gardner et al., 2012; Spratlen et al., 2017) and type of SNP .
The present study aimed to examine the influence of genetic predisposition (SNPs in AS3MT, MTHFR, AQP4, AQP9, SELENOP, INMT, and MT2A) and selenium status on arsenic methylation efficiency and arsenic urine concentrations in Croatian-Slovenian woman (pregnant and non-pregnant) and children exposed to low levels of inorganic arsenic. The influence of SNPs on Se urine concentrations was simultaneously tested as well.
Material and methods

Study population
Study includes a Croatian-Slovenian population (n = 506) with low As exposure mainly through seafood consumption. Participants were recruited between 2006 and 2011 within the wider EU-funded PHIME-FP6 project ('Public Health Impact of long-term, low-level, mixed element exposure in susceptible population strata') and/or between 2013 and 2017 within the follow-up EU-funded CROME-LIFE+ project ('Cross-Mediterranean Environment and Health Network'). All participants provided signed informed consent, and the research protocol of the study was approved by the National Ethics Committee of Croatia and Slovenia.
As shown in Fig. 1 , the study population consisted of three main groups: pregnant women (A; n = 136, aged 20-44 years; residents of the coastal city of Rijeka, Croatia, and its surroundings) with a small subgroup of the same women resampled 8-9 years after pregnancy (A 1 ; n = 21, aged 29-48 years); non-pregnant mothers (B; n = 176, aged 30-51 years, residents of Ljubljana and its surroundings); and children of non-pregnant women (C; n = 176, aged 7-8 years; C 1 : 86 girls and C 2 : 90 boys). Information regarding their basic characteristics (age, weight, height…), socioeconomic status, lifestyle, and nutritional habits were acquired through interviewer-administered questionnaires. The residential areas-Rijeka and Ljubljana-were not far apart (< 150 km) and before 1991, they both belonged to the former Yugoslavia and had very balanced socioeconomic status.
The reported seafood intake frequency data (intake frequency of fish, crustaceans, molluscs, etc.) with serving of 150 g were transformed into a daily seafood intake index, as previously explained by Valent et al. (2013) and Miklavčič et al. (2013) .
The As levels in drinking water were < 0.1-0.55 µg/L in Ljubljana (unpublished data, Zuliani and Šlejkovec 2014, 2018) and 0.05-1 µg/L in Rijeka (measured in 2007 Rijeka (measured in , 2014 Rijeka (measured in and 2016 (Fiket et al., 2007; Piškur, 2016 Piškur, , 2014 ). WHO's permissible exposure limit is 10 µg/L (World Health Organization, 1993).
Samples and sampling data
Peripheral venous blood/plasma and urine spot samples were obtained for all study groups (A(A''), A 1 , B, and C). Saliva was obtained for non-pregnant women and children (B and C). Fig. 1 shows the details of the collected samples. Pregnant women (A(A'')), sampling was performed during a regular medical exam at the University Hospital of Rijeka in the 3 rd trimester of pregnancy; as previously described in detail by (Miklavčič et al., 2013; Valent et al., 2013) . For non-pregnant women and children, samples were collected at appointed visits in paediatric clinics in Ljubljana, Slovenia (B and C), or the University Hospital of Rijeka (A 1 ). Urine samples (~50 mL) and peripheral blood (16 mL for mothers and 6 mL for children) were obtained by trained personnel according to the standard protocol. Before analysis, samples were divided into aliquots and stored at −80°C. Saliva samples (~1 mL) were collected using an Oragene DNA selfcollection kit (OG-500) (DNA Genotec Inc), and stored at room temperature (~25°C).
As and Se determination
Total As and Se determination in blood, urine and plasma (Se only)
Pregnant women (A): Total As and Se levels in blood and urine were measured at the Jožef Stefan Institute, Department of Environmental Sciences, Slovenia, using an octapole reaction system inductively coupled plasma mass spectrometer (ORS ICP-MS, 7500ce, Agilent Technologies, Santa Clara, CA, USA) equipped with an ASX-510 Autosampler (Cetac), as described in detail in a previous study (Miklavčič et al., 2013) . The limit of detection (LOD) calculated as three times the standard deviation of blanks for As and Se was respectively 0.1 and 5.0 ng/g in blood and 0.3 and 4.0 ng/mL in urine.
Se in plasma was measured at the laboratory of the Clinical Chemistry and Biochemistry Institute of the University Medical Centre, Ljubljana, Slovenia, by electrochemical atomic absorption spectrometry (ETAAS) with LOD of 0.2 ng/mL.
Non pregnant women and children (B, A 1 and C): Total As and Se levels in blood, plasma (Se only), and urine were measured at the laboratory of the Clinical Chemistry and Biochemistry Institute of the University Medical Centre Ljubljana, Slovenia. An aliquot (0.2 mL) of the sample was diluted with 2 mL of 1.02% (v/v) ammonium hydroxide (Fluka Analytical TraceSELECT Ultra) solution containing 0.06% (v/v) Triton X-100 (Aldrich Chemistry, Trace Metal Basis), 1.8% (v/v) 1-butanol (Sigma Aldrich, ACS reagent), 0.06% (w/v) ethylenediaminetetraacetic acid disodium salt dehydrate (Aldrich Chemistry, Trace   Fig. 1 . Study selection scheme: participant groups with collected samples.
A. Stajnko et al. Environmental Research 170 (2019) 301-319 Metal Basis), and internal standard solution (ICP-MS Internal Std Mix, Agilent Technologies). External calibration with a multi calibrator IV-STOCK-27 (Inorganic Ventures) was used for quantification. Prepared solutions were measured using an ORS ICP-MS (7700 ×, Agilent) equipped with an Integrated Autosampler (Agilent). The instrument conditions were as follows: micromist nebuliser, Scott-type spray chamber with lower temperature of 2°C and higher temperature of 16°C, plasma gas flow rate of 15 L/min, carrier gas flow rate of 1.07 L/ min, RF power of 1550 W, and reaction cell helium gas flow rate of 10 mL/min for Se and 5 mL/min for As. The instrument was tuned daily. The reference materials used to check the accuracy of the measured trace elements were whole Blood L-1 (lot no. 1406263, Sero) and L-2 (lot no. 1406264, Sero), Seronorm Trace Elements Serum L-1 (lot no. 1309438, Sero), and Seronorm Trace Elements Urine L-1 (lot no. 1011644, Sero) and L-2 (lot no. 1403081, Sero). The values found were in good agreement with the reference values. LODs were calculated based on 3-day measurements (in 20 repetitions) of Seronorm Trace Elements Urine L-1 following the recommendation of the Environmental Protection Agency. LODs in blood, plasma (Se only), and urine were 0.1 ng/mL for As and 1.0 ng/mL for Se. The use of different LODs in the measurement of As (urine) and Se levels should not have had a significant impact on the statistical analysis because the number of participants with levels below LODs was negligible (11 pregnant women and 3 non-pregnant women for Se in urine and one non-pregnant woman for As in urine).
Determination of As metabolites in urine
Biologically active arsenic metabolites, namely AsIII, AsV, MMA, and DMA, were measured in all urine samples, and their sum (U-∑As M ) was used as an estimation of the exposure to iAs. Nontoxic, readily eliminated arsenobetaine (AsB), generally the major component of seafood As, was measured in a subset of urine samples (n = 31) or was otherwise calculated (U-cAsB) by subtracting the sum of AsIII, AsV, MMA and DMA from total urine As (U-As). U-cAsB was used as an estimation of foodborne AsB, although this estimation also included potential traces of undefined metabolites from food consumption (arsenocholine, arsenolipids, arsenosugars, etc.). The proportion (%) of calculated AsB was calculated based on U-As.
AsIII, AsV, MMA, and DMA were determined in thawed urine samples using high-performance liquid chromatography (HPLC) with an anion exchange column (Hamilton PRP-X100; 20 mM KH 2 PO 4 , pH 6.1 as mobile phase) coupled with hydride generation atomic fluorescence spectrometry (HG AFS), as described previously (Šlejkovec et al., 2008) . Arsenobetaine (AsB) was determined using a cation exchange column (Zorbax 300-SCX; 10 mM pyridine, pH 2.75 as mobile phase) and UV-decomposition (3% NaOH/3% K 2 S 2 O 8 , 3 mL/min) before HG. The LODs were 0.1 ng/mL for AsIII, 0.2 ng/mL for MMA and DMA, and 1 ng/mL for AsB.
The presence of undefined As species was tested by mass balance analysis (total As versus the sum of measured metabolites-AsIII, AsV, MMA, DMA and AsB-in samples with exact measurements of all As variables in urine (n = 31). The average (arithmetic) share of analysed metabolites was 89% in the range of 66-100%. Mass balance was particularly good in samples with higher As levels. Difference in samples with low As levels (n = 9, 3.44-22.0 ng/mL) can be attributed to methodological reasons and analytical measurement uncertainty related to very low concentration levels. Differences for samples with higher levels (n = 5, 273-429 ng/mL) might be explained by the matrix effect binding of some As species (As-metallothionein, As-Cys, etc.) on the HPLC column that could not be detected; this phenomenon was described previously by Šlejkovec et al. (2008) , Cullen (2014), and Stice et al. (2016) .
Adjustment of urine biomarkers for differences in diuresis between samples
Specific gravity (SG) was used for adjusting the total As and Se in urine, as described previously (Suwazono et al., 2005) . The SG of each sample was determined using a PAL-10S refractometer (Atago®, Japan) with measurement range of 1.000-1.060. Adjustment by creatinine has previously been reported as being inappropriate because (1) physiological interactions between creatinine and arsenic in urine (through common one-carbon metabolism) lead to possible underestimation of As exposure (Tseng, 2009) and (2) creatinine at low levels of exposure normalisation can even introduce mathematical uncertainties (Bernard, 2016; Hoet et al., 2015; Stajnko et al., 2017; Tang et al., 2015) .
As methylation efficiency
Methylation efficiency or methylation capacity is generally estimated by proportions of biologically active urine metabolites (AsIII%, MMA%, and DMA%) considering the total urine As or their sum in case of known seafood consumption to exclude nontoxic arsenobetaine. In addition, primary, secondary and total methylation index (PMI=MMA/ iAs, SMI=DMA/MMA and TMI = (MMA+DMA)/iAs, respectively) are usually used as indicators for evaluating the methylation capacity of individuals. We used both types to achieve better comparison with literature. Shares of biologically active metabolites were calculated based on their sum.
DNA extraction and SNP genotyping
DNA was mostly extracted from blood samples (1-3 mL) using a FlexiGene® DNA Kit (Qiagen, Hilden, Germany), and in cases where blood samples for extraction were unavailable (group C and eight women from group B), it was extracted from saliva samples (0.5 mL) using PrepIT-L2P (DNA Genotec Inc.). The concentration and purity of isolated DNA was determined by spectrophotometry using a NanoDrop 2000c UV-VIS spectrophotometer (ThermoFisher Scientific, USA).
SNPs in seven genes-AS3MT, MTHFR, AQP4, AQP9, SELENOP, INMT, and MT2A-were selected based on a (1) literature search, (2) position in gene (preferably: exon > regulatory regions > intron), and (3) availability of predesigned TaqMan® SNP Genotyping Assays. Accordingly, we have chosen 17 SNPs (Table SP1) : eight for AS3MT (rs7085104, rs3740400, rs3740393, rs3740390, rs11191439, rs10748835, rs1046778, and rs7897654); two each for MTHFR (rs1801131 and rs1801133), SELENOP (rs7579 and rs3877899), and AQP9 (rs2414539 and rs17240643); and one each for AQP4 (rs9951307), INMT (rs6970396), and MT2A (rs28366003). Two SNPs, rs7897654 in AS3MT and rs17240643 in AQP9, were genotyped only on a subset of participants; owing to their complete LD with two other SNPs (rs1046778 and rs2414539, respectively) in the corresponding genes, they were excluded from further analysis. The remaining seven AS3MT SNPs were marked as SNP1-7 based on their subsequent position in the gene.
All SNPs were genotyped using pre-designed TaqMan® SNP Genotyping Assays (Applied Biosystems, Foster City, CA, USA). Detailed information on the studied SNPs, including chromosome position, functional region, nucleotide or amino acid position, minor allele frequency (MAF), and TaqMan ID, is shown in the supplement (Table  SP1 ). The reaction volume was 5 µL, and it contained 2.5 µL of TaqMan® Universal Master Mix II with UNG (Applied Biosystems, Foster City, CA, USA), 1.875 µL of ultrapure nuclease-free water (Life Technologies, CA, USA), 0.125 µL of 44X TaqMan probe/primer mix, and 0.5 µL of genomic DNA. Amplifications and fluorescence detection were performed using LightCycler® 480 Instrument II and LightCycler® 480 Software version 1.5.1 (Roche). PCR cycling included (1) pre-PCR (1 cycle: 50°C for 2 min), (2) activation (1 cycle: 95°C for 10 min), (3) annealing and amplification (45 cycles for rs7579 and 50 cycles for all others: 95°C for 15 s and 61°C for 1 min), and (4) post-PCR (1 cycle: 40°C for 30 s). In each genotyping run, a subset of randomly selected samples was repeated as a control (~10%).
Construction of AS3MT haplotypes
In comparison with haplotypes reported for populations from Argentina and Bangladesh constructed from eight SNPs (Engström et al., 2011) , we selected seven SNPs and constructed our 'protective'/ 'neutral' haplotypes using six of them (as described below).
We performed LD analysis and construction of AS3MT haplotypes by using Haploview (version 4.2, Day Lab at the Broad Institute Cambridge, USA). Fig. 2 shows LD (R 2 ) patterns for seven AS3MT SNPs in the main studied groups. They were similar for all study groups, with the strongest LD observed for SNP1 and SNP2 (R 2 = 0.84-0.91) and no or very low LD for SNP5 compared to the other SNPs (R 2 ≤ 0.27). Such results were observed in other studies as well (De la Rosa et al., 2017; Drobná et al., 2016; Engström et al., 2015) . Owing to the strong LD between both haplotype blocks (multilocus D prime, 0.88-0.91; Fig. 2 ), we combined them into one haplotype but excluded SNP5 (rs11191439) owing to its very low LD compared with other SNPs. As such, we identified eight haplotype versions (with a sequence of six SNPs in 5′-3′ order based on their position in the gene, as seen in Fig. 2 ) that had frequency above 1%. In the present study, statistics are presented for the carriers versus non-carriers of at least one copy of the 'protective' AS3MT haplotype with a sequence of minor alleles GGCTAC and carriers versus non-carriers of two copies of common alleles, namely, 'neutral' AS3MT haplotype with sequence ATGCGT.
Statistical analysis
Descriptive statistics, performed separately for each (sub)group, was used to assess the analyte concentrations that are expressed in terms of geometric means with 95 confidence interval and median with minimum and maximum (GM, 95 CI and P50, min-max), and age, weight, height, and BMI were expressed in terms of arithmetic means with minimum and maximum (x , min-max). The frequencies of genotypes and alleles were expressed in terms of number and/or percentage N (%). Analyte values below the LOD were substituted with a value of LOD/2.
Comparisons of As and Se parameters and SNP frequencies between groups
The differences in the distribution of As and Se parameters between (sub)groups were assessed using a non-parametric Mann-Whitney U test. Pearson's chi-squared test was used for comparing the SNP genotypes and allelic frequencies between groups and to evaluate the consistency of genotype frequencies with the Hardy-Weinberg equilibrium (HWE, p > 0.05).
Comparison of As and Se parameters between carriers and noncarriers of minor alleles inside each group
Owing to the relatively low number of participants, low number of minor homozygotes in the case of some SNPs (Table SP2) , and low As exposure biomarkers, all SNPs and AS3MT haplotypes in statistical analysis were used as binary variables. Therefore, the participants of each study group were stratified based on the presence/absence of minor alleles in the case of individual SNPs or the presence/absence of AS3MT haplotypes. The differences in urinary As and Se concentrations and As methylation parameters (all representing dependent continuous variables) between carriers and non-carriers of the studied SNPs alleles or haplotypes (representing independent categorical variables) were tested by a non-parametric Mann-Whitney U test.
Linear regression models
The possible influences of SNPs and AS3MT haplotypes for each group separately were further evaluated in multiple linear regression models by adjusting for several variables. Possible collinearity between variables was assessed by the variance inflation factor test. The age, weight, height, BMI, B-As, and P-Se were included as continuous variables and parity (0 = zero delivery versus 1 = 1-3 deliveries), child sex, gender, ever-smoking status (in last two years: yes vs. no), and smoking parents (at least one vs. none), as categorical variables. Regression models with AsIII%, MMA%, DMA%, PMI, SMI, TMI, AsIII, MMA, DMA, ∑-UAs M , or U-Se as outcome variables (Y) were specific for each of the main study groups as follows:
-pregnant women (A), Y = β 1 x (SNP of interest/haplotype) + β 2 × (age) + β 3 x (prepregnancy BMI) + β 4 x (child sex) + β 5 x (ever smoking) + β 6 x (parity) + β 7 x (P-Se) + β 8 x (B-As) -non-pregnant women (B), Y = β 1 x (SNP of interest/haplotype) + β 2 x (age) + β 3 x (BMI) + β 4 x (ever smoking) + β 5 x (P-Se) + β 6 x (B-As) -children (C), Y = β 1 x (SNP of interest/haplotype) + β 2 x (gender) + β 3 x (height) + β 4 x (weight) + β 5 x (smoking parents) + β 6 x (P-Se) + β 7 x (B-As)
Statistical analysis was performed using STATA12/SE statistical software on ln-transformed data to approximate the normal distribution with the level of statistical significance set at p < 0.05 (two-sided). The results were visualized using OriginPro 2017 software (OriginLab, Northampton, USA) and Microsoft Excel 2016. A. Stajnko et al. Environmental Research 170 (2019) 301-319 
Confounders
Confounders (blood As, plasma Se, age, BMI, ever smoking status, parity, child sex, gender, weight, height, smoking of parents) were selected based on their potential biological relevance in As metabolism, as reported previously Khairul et al., 2017; Taylor et al., 2017; Tseng, 2009 ) and based on the availability of their data in the present study. The known influence of gestation week (GW) at sampling was not included owing to the missing information for 55 individuals (Gardner et al., 2011; Hopenhayn et al., 2003) . When tested as a confounder in regression models for the remaining 81 women, its influence was insignificant. Despite the importance of folate supplementation (increase in DMA%; Gamble et al., 2007 Gamble et al., , 2006 , its influence during pregnancy was not included either. The questionnaire data were too scarce. However, gynaecologists regularly prescribe its supplementation in both countries.
The possible release of residual tissue-bound As as DMA or/and as iAs and MMA during pregnancy, as mentioned in literature (Hopenhayn et al., 2003) , is believed to be negligible in the present study owing to the very low levels of total As.
As in blood was chosen as a confounder, unlike in most similar studies, where the sum of urine As metabolites was used to adjust for iAs exposure levels. The range of iAs exposure levels for our population is relatively small; therefore, we did not expect its significant modification on the tested associations. Additionally, at low levels of As exposure, recent food consumption (especially seafood) could considerably influence the assessment of urine As metabolites; therefore, food intake for at least 2-3 days before urine sampling should be recorded (Molin et al., 2015; Taylor et al., 2017) . We were missing such information, and the reliability of self-reported seafood intake could be questionable. As in blood well reflects recent exposure through food (Fowler et al., 2015) and internal As levels influenced by physiological variations (Balakrishnan et al., 2018) .
Plasma selenium was used as the optimal (available) indicator of selenium nutritional status, as it is known to have an impact on As excretion (Alexander, 2015; Sun et al., 2014) .
The gender of the foetus was included due to its recently reported effect on associations between genetic polymorphisms (AS3MT, AQP9) and urine arsenic metabolites in pregnant women Winterbottom et al., 2017) .
Results and discussion
The three main study groups were age-matched pregnant women in the 3rd trimester and non-pregnant women and 7-8-year-old children of non-pregnant women (girls and boys). A subset of 21 pregnant women from group A was resampled 8-9 years after pregnancy to perform a direct individual comparison of their As and Se status during and after pregnancy. Fig. 1 shows the sampling scheme for each group and subgroup and Table 1 , their demographic and lifestyle characteristics. Table 2 shows arsenic and selenium parameters in the collected samples.
Arsenic levels
Observed total As levels were very low to moderate. GMs for main groups were 0.38-2.59 ng/g (ng/mL) in blood and 4.33-24.9 ng/mLSG in urine (Table 2 ). They were below or within the ranges usually reported for a general population with no known high As exposure: 2-23 ng/mL for blood (as a reference interval) (International Programme on Chemical Safety, 2004) and 5-50 ng/mL for urine (Fowler et al., 2015) . In agreement with the self-reported daily seafood intake, the highest levels were observed in the group of pregnant women.
The sum of biologically active metabolites in urine was expected to be similar and very low for all groups; that for individuals with no Table 1 Basic characteristics of population groups as shown in Fig. 1 . (176) 0.14; 0-0.69 (89) 0.14; 0-1.14 (90)
Parity ( (17) 16 (18) 14 (16) Age, weight, height, BMI, and GW presented as x ; min-max (N); daily seafood intake presented as GM; min-max (N). a Significant difference (p < 0.05) between non-pregnant (B) and pregnant women (A).
b Pre-pregnancy weight and pre-pregnancy BMI.
c Current smokers and those that quit smoking in the last two years.
d
Children with at least one smoking parent; GW, gestational week at the time of sampling; Daily seafood intake factor was calculated as presented in Miklavčič et al. (2013) .
Table 2
Levels of As and Se parameters in population groups as shown in Fig. 1 . A. Stajnko et al. Environmental Research 170 (2019) 301-319 known exposure to inorganic arsenic the sum of biologically active metabolites in urine is reported to be generally below 10 ng/mL in European countries (International Programme on Chemical Safety, 2004). Indeed, the sums were much lower than total urine As and below 10 ng/mL (GMs 1.87-3.23 ng/mL SG ) ( Table 2) . Only a few individuals exceeded 10 ng/mL (13 pregnant women, 2 non-pregnant women and 1 child). However, as in the case of total As, the sum of metabolites was significantly higher among pregnant women, perhaps due to the possible presence of minor amounts of DMA derived from (sea)food items (Taylor et al., 2017) . Seafood can contain As in the form of DMA and/or As-sugars that are further metabolized into DMA (Taylor et al., 2017; Thomas and Bradham, 2016) . Therefore, in some more recent studies, exposure to iAs is estimated by the sum of AsIII, AsV, and MMA only, and DMA is excluded (Hata et al., 2016) . Upon excluding DMA, the differences between our groups lost statistical significance (Table 2) . Therefore, in general, in all groups the exposure to iAs was almost equal and very low, as the greatest amounts of urine As were found in the fraction of calculated AsB. Regardless of the group, the calculated As was 0-99% with arithmetic means: 53% for all, 78% for pregnant women, 47% for non-pregnant, and 42% for their children. In participants with urine As > 50 ng/mL (N = 40), the percentage range was 73-99% with consequently higher arithmetic mean of 94%. The presence of undefined As species was tested by mass balance analyses for a few samples (n = 31). We observed some differences between total As levels and the sum of measured metabolites; however, these were within the ranges attributed to analytical reasons, as described in the material and methods section. Skröder et al. (2016) observed a similar phenomenon with mass balance in a study on Bangladeshi children exposed to high iAs levels. They reported a large difference between all analysed species and total As for a subset of samples within the highest quartile of U-Se levels (18-55 ngSe/mL SG ) and speculated on the possible elimination of the As-Se complex with urine. However, our tested cases with lower iAs and even higher urine Se levels did not confirm such trends (51-229 ngSe/mL SG ).
Selenium levels
Selenium can substantially influence arsenic metabolic pathways and toxicity as mentioned in introduction (Alexander, 2015; Falnoga et al., 2014; George et al., 2013; Sun et al., 2014; Zeng et al., 2005) . Selenium deficiency and variability in its metabolic pathways can decrease the formation of arsenic-selenium complexes and, consequently, As elimination. Blood and plasma selenium can be used as rough estimates of Se nutritional status and general antioxidant status (Alexander, 2015) . In the present study, GMs for Se in blood (plasma) and urine for the main investigated groups were respectively 94.1 ng/g (54.8 ng/mL) and 20.8 ng/mL SG for pregnant women; 105 ng/mL (82.3 ng/mL) and 9.33 ng/mL SG for non-pregnant women; and 82.3 ng/ mL (65.8 ng/mL) and 13.8 ng/mL SG for children (Table 2 ). They are within or close to the normal reference intervals as set for the worldwide general population by Roberts et al. (2012): 58-234 ng/mL for blood (group not specified), 55-134 ng/mL for plasma of 4-16-year-old children, and 63-160 ng/mL for plasma of adults. Plasma levels are within the range reported for similar European study groups in terms of age and pregnancy: 34-63 ng/mL for pregnant women (3 rd trimester), 66-97 ng/mL for non-pregnant women, and 53-75 ng/mL for children (Stoffaneller and Morse, 2015; Zachara, 2016) . They are also above or close to the level required for sufficient activity of glutathione peroxidase (63.1 ng/mL) commonly used as a better marker for Se adequacy (Stoffaneller and Morse, 2015) . Decrease in blood/plasma Se during pregnancy is attributed to many factors like Se transportation through the placenta to the developing foetus (Zachara, 2016) and to a pregnancy-related increase in blood and stroke volume, heart rates and plasma volume, faster metabolism, and increased urine elimination (increase in renal plasma flow, glomerular filtration rate up to 85%, and decreased tubular A. Stajnko et al. Environmental Research 170 (2019) 301-319 reabsorption) (Cheung and Lafayette, 2013; Gardner et al., 2011; SomaPillay et al., 2016) . For children, the situation may be related to their faster metabolism at this age (Hall et al., 2009 ). Owing to the small number of samples, the gender differences were noticed for blood Se only. Levels were slightly but significantly higher for girls than for boys (GM = 85.0 ng/mL for girls and 79.8 ng/mL for boys), as shown in Table 2 . Similarly, in a study on British children (174 boys and 132 girls of age 7-10 years) Bates et al. (2002) reported significantly higher erythrocyte Se levels among girls than boys (GMs = 1.53 vs 1.41 µmol/L, respectively). Concomitant higher urine Se levels observed in pregnant women and children are less known but are obviously related to similar metabolic reasons and relatively good nourishment with selenium. In case of deficiency, its urine excretion would be diminished (Alexander, 2015) .
As methylation efficiency
As in studies with higher iAs exposure (Gardner et al., 2011; Hopenhayn et al., 2003) , the most efficient As methylation was observed for pregnant women. They had significantly lower AsIII% and MMA%, higher DMA%, and, accordingly, lower PMI with higher SMI and TMI than the non-pregnant group (Table 2) . The same differences, although not significant for each parameter, were confirmed for the 21 selected pregnant women by comparing their status during pregnancy and non-pregnancy, although they were from a different region with higher absolute levels of blood As and higher pre-pregnancy blood (plasma) ( Table 2 ). Some of the various factors (seafood intake, BMI, age, selenium levels, etc.) which can influence arsenic metabolic pathways were considered during association analysis between SNPs and arsenic (and selenium) parameters for each group separately. As discussed in the previous section, pregnancy is accompanied by various anatomical and physiological changes, and some of them are at their peak during the 3 rd trimester (Cheung and Lafayette, 2013; Soma-Pillay et al., 2016) . They influence the pathways and concentrations of essential elements like selenium, and similarly, they can influence As metabolism on more levels (Engström et al., 2011; Gardner et al., 2011; Li et al., 2008; Tseng, 2009 ). More efficient As methylation was also observed among children when compared to their mothers; children had lower MMA% and higher DMI% with higher secondary and total methylation index. Literature differences in As methylation capacity between children and adults from regions with high iAs exposure are inconsistent (Bangladesh, Argentina, Chile) (Chowdhury et al., 2003; Skröder Löveborn et al., 2016; Shen et. al, 2016) , and no studies with low As exposure are reported. According to Hall et al. (2009) , children at this haplotype consisting of SNPs (allele) in 5′-3′ order: a rs7085104(G), rs3740400(G), rs3740393(C), rs3740390(T), rs10748835(A), and rs1046778(C) and b rs7085104(A), rs3740400(T), rs3740393(G), rs3740390(C), rs10748835(G), and rs1046778(T); * sig difference between groups A and C 1, **sig difference between groups C 1 and C 2 .
A. Stajnko et al. Environmental Research 170 (2019) 301-319 young age (7-8 years) are in a period of rapid growth and increased physical activity that requires upregulation of various metabolic pathways, this can also contribute to more efficient As methylation, increased elimination, but also to higher retention of protein-bound As in body tissues (Hall et al., 2009) . Differences between girls and boys are evident although statistically insignificant (Table 2) . Literature data are again inconsistent (Recio-Vega et al., 2016; Skröder Löveborn et al., 2016; Torres-Sánchez et al., 2016) .
AS3MT, MTHFR, AQP4, AQP9, SELENOP, INMT, and MT2A polymorphisms and their relationship with As and Se (regression models)
The influence of genetic polymorphisms (SNPs) of selected genes on urine As/As metabolites Se was studied for each study group separately. All genotyped SNPs-seven in AS3MT, two in MTHFR and SELENOP; and one each in INMT, AQP4, AQP9, and MT2A-were in HardyWeinberg equilibrium (p > 0.05).
In comparison with similar association studies, we were dealing with very low levels of iAs metabolites in urine (median range: 1.76-3.03 ng/mL SG, n = 488). For example, these were at least 30-60 times lower than those reported for Argentina (median: 200 ng/mL SG , n = 172) and Bangladesh (median: 100 ng/mL SG , n = 361) (Engström et al., 2011) and around two times lower than those reported for European countries such as Hungary, Romania, and Slovakia with known hotspots of iAs in drinking water (median: 8 ng/mL SG , n = 415) (Lindberg et al., 2007) . Only Balakrishnan et al. (2018) have recently reported ethnicity and genetic influences on As methylation in six US communities exposed to similarly low levels of iAs (median range: 2.3-4.9 ng/mL SG , n = 264). Table 3 shows minor and common alleles frequencies of all studied SNPs and AS3MT haplotypes ('protective' and 'neutral'); the frequencies of SNPs' genotypes are given in Table SP2 in the supplements. Allele frequencies are relatively close to those reported for populations with European ancestry (HapMap, CEU, TSI) (National Center for Biotechnology Information, 2018) (Table SP1) , and as expected, there were no significant differences in allele frequencies between the main study groups. The only difference observed for AS3MT SNPs (rs7085104 and rs3740400) was significantly higher MAF for girls than boys (Table 3 ). It could be coincidental due to low number of subjects in each subgroup.
Allele frequencies of study groups
Our central focus was on AS3MT as the best-studied gene in relation with As metabolism. Fig. 3 shows AS3MT SNPs minor allele frequencies compared with those for populations from other countries having similar or higher exposure to iAs. Our frequencies are significantly lower than those reported for populations known to be genetically adapted to high iAs exposure through many generations, such as Argentina (SAC, 2x higher for all SNPs and even~8x for SNP4) (Schlebusch et al., 2015a (Schlebusch et al., , 2015b (Schlebusch et al., , 2013 and Chile (differences are smaller) (Apata et al., 2017) . They are also lower than those reported for the populations of China and Japan that could have been adapted to As through their historical dietary habits, with higher iAs intake through dietary sources like rice and algae (Thomas and Bradham, 2016) . Less evident are differences with Bangladesh, having iAs-contaminated water throughout the country during the last century; frequencies were significantly higher for only two AS3MT SNPs and even lower for one. For the Nigerian population (Africa), all frequencies were lower than ours.
The frequencies of the 'protective' haplotype are reported less often. They were between 9% and 12%; these are close to those reported for European countries (Romania, Slovakia, and Hungary: 12%) and considerably lower than those found in countries with known (or supposed) historical exposure to high iAs from drinking water (Argentina: 70%, Chile: 48-68%, and Peru: 50%) (Apata et al., 2017 'protective' haplotypes reported in literatures and corresponding minor haplotypes in our population; we constructed our complimentary sets of haplotypes based on the combination and number of SNPs (Fig. SP1) . Table 4 summarizes the significant differences in the data distribution of various urine As and Se parameters between the carriers and non-carriers of minor alleles for each SNP (or haplotype) in each group (pregnant -A, non-pregnant -B, children -C). Results that were significant in multiple regression models adjusted for various confounders are indicated in bold. Obviously, the influence of various SNPs on the levels of urine As/As metabolites and Se was minimal although significant. The correspondingly low strength of these associations, presented by the coefficient β, is shown in Fig. 4 . The influences of confounders (beta coefficients) are summarised in a generalized way in Table 7 . Data (ranges) are based on all individual linear regression models for SNPs of genes that were found to have a significant effect on at least one As or Se parameter (specified in Fig. 4) .
Associations between studied SNPs and selected As parameters
Associations between SNPs and As(Se) parameters were the most significant among non-pregnant women, less so among pregnant women, and almost absent among children. They are discussed separately for each gene below; all observed influences are commented on in relation to the effects of minor alleles.
AS3MT.
Despite the very low levels of biologically active As metabolites (Table 2) , we observed the 'protective' effect of six individual SNPs (minor alleles) and their haplotype in non-pregnant women only (lower MMA% and higher SMI) (Table 4) . Associations were completely absent among pregnant women and almost absent among children (an exception was the influence of SNP4). The possible negative effect of 'neutral' haplotypes (common alleles) was not observed. In general, regression models confirmed the results obtained from bivariate comparisons. Table 5 shows comparisons with existing studies conducted on women Engström et al., 2011 Engström et al., , 2007 , children (Recio-Vega et al., 2016) , and mixed populations (Balakrishnan et al., 2018; Chen et al., 2017; Lindberg et al., 2007; Xu et al., 2016) . In general, these individual SNPs and their 'protective' haplotypes were found to be strongly linked with more efficient As methylation in the populations with high iAs exposure. In several studies, they consistently show associations with lower levels of urine AsIII% and MMA% and higher DMA% accompanied with higher secondary and total methylation efficiency index in general populations and pregnant women.
As in the study by Xu et al. (2016) for a Mexican population, we observed the strongest influence for rs3740393 that was significantly associated with almost all As methylation parameters (AsIII%, MMA%, DMA%, SMI, and TMI). The association of rs11191439 (SNP5) with poorer As methylation as found in populations with high iAs exposure levels (Bangladesh and Mexico) (Engström et al., 2011; Recio-Vega et al., 2016) (Table 5) was not observed in our study (Table 4 and Fig. 4) . Interestingly, in a study on Central European populations (Romania, Hungary, and Slovakia) exposed to low levels of iAs, Lindberg et al. (2007) observed an association among men but, as in our study, not among women (n = 415, 225 men; median U-∑As M : 8 ng/mLSG).
Regarding our pregnant women and children, it seems that at low iAs exposure, the altered and more variable physiology during pregnancy and children's growth period (Hall et al., 2009; Soma-Pillay et al., 2016) dominates over the genetic influences on iAs metabolism. This is also in agreement with Gardner et al. (2012) , who found a stronger effect of pregnancy than of the AS3MT haplotype on the As metabolite pattern of pregnant Bangladeshi women (n = 303; median U-∑As M : 90 ng/mL SG ; GW 30). However, unlike in our study, they and some other research groups studying pregnant women in Argentina (Engström et al., 2007) and Mexico ) observed significant influences of SNPs on As metabolite patterns (Table 5) , most probably owing to the much higher iAs exposure levels in their studies.
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MTHFR.
MTHFR is a coding folate-metabolizing enzyme, and it has been studied frequently in relation to As metabolism . We tested two MTHFR SNPs, rs1801131 and rs1801133, whose minor alleles are related to a 20-35% decrease in the MTHFR activity of the general population (Vidmar et al., 2016) . Lower activity leads to lower levels of folate and consequently, lower SAM (main methyl donor for As methylation) and poorer As methylation . However, this effect is probably seen only at higher As exposure levels in the general population (Spratlen et al., 2017) . Our results obtained from simple bivariate comparisons did show a significant difference for both SNPs among pregnant women. rs1801131 was associated with lower AsIII% and DMA% and higher TMI and rs1801133, with higher AsIII% and lower DMA%, SMI, TMI, and U-∑As M (Table 4 ). As such, trends for the second SNP are consistent with the observations from the literature; Table 6 shows a detailed comparison with literature data. However, after adjusting for confounders, no association was significant (Fig. 4) . This could be attributable to low levels of As and sufficient levels of folate, which is regularly prescribed during pregnancy as a supplement by gynaecologists. For clearer interpretation, folate levels should be measured.
AQP4 and AQP9.
Human aquaporins (AQP0-AQP12) are membrane proteins that are important for the transport of water, small solutes, and gases across cellular membranes in various organs (Day et al., 2014) . Some aquaporins like AQP3, AQP4, AQP7, AQP9, and AQP10 have been previously recognized to play an important role in the cellular uptake of AsIII in various organisms including humans (Calatayud and Laparra Llopis, 2015; Calatayud et al., 2012; Liu et al., 2002; Matsuzaki et al., 2004; Mukhopadhyay et al., 2014; Roggenbeck et al., 2016) . In human As metabolism, they have been mainly studied on the basis of their gene expression; As 2 O 3 uptake was associated with expression of AQP9 (in leukemic cells) (Khairul et al., 2017) and AQP4 (in Caco-2 cell lines as model for intestinal epithelium) (Calatayud and Laparra Llopis, 2015; Calatayud et al., 2012) . However, no studies have thus far investigated the influence of AQPs SNPs on As metabolism. We tested such relations for AQP4 SNP rs9951307 and AQP9 SNP rs2414539. AQP4 represents the main water channel in the brain, however, it is also expressed in the kidney, gastrointestinal tract, and placenta (Day et al., 2014; Matsuzaki et al., 2004; Spratlen et al., 2017) . Bivariate analysis and regression models clearly showed the significant association of AQP4 rs9951307 with poorer As methylation among pregnant women. They had higher concentration and percentage of AsIII and lower PMI and TMI indexes (Table 4 and Fig. 4) . The results can be explained by the role played by AQP4 in kidney water flow regulation (better reabsorption of water into blood) (Day et al., 2014 ) and lower (Engström et al., 2011) , Chile (n = 491-493) (De la Rosa et al., 2017) , , Bangladesh (n = 351-360) (Engström et al., 2011) ; *observed significant differences in allele frequency with our population (red reference line) as assessed using Pearson's chi-squared test, p < 0.05). A. Stajnko et al. Environmental Research 170 (2019) 301-319 AQP4 expression among rs9951307 minor allele carriers (Kleffner et al., 2008) . We suppose that pregnancy-related enhanced water flow and decreased water reabsorption in the kidney (Cheung and Lafayette, 2013; Soma-Pillay et al., 2016) combined with AQP4 downregulation resulted in increased urine elimination and, consequently, higher urine concentration of AsIII. If downregulation also affects the placenta, its effect on urine AsIII is even higher. AQP9 is highly expressed in hepatocytes (primary site of As methylation) where it plays a major role in the cellular uptake of AsIII. Based on experimental studies on rats, it also potentially plays a role in the efflux of As compounds (MMA and DMA) into the blood from where they are eliminated into the urine (Day et al., 2014; Mukhopadhyay et al., 2014; Roggenbeck et al., 2016) . Non-pregnant women carrying a minor allele of AQP9 rs2414539 had higher iAs methylation capacity (lower AsIII% and higher PMI and TMI and higher urine concentrations of MMA, DMA, U-∑As M , and U-Se (Table 4 and Fig. 4) ). These results could suggest higher uptake of AsIII into hepatocytes, leading to its methylation and increased elimination of methylated forms with urine. Of course, at higher exposure levels the same process can be damaging if AS3MT cannot cope with (and methylate) all accumulated AsIII. Particularly interesting is the positive association with urine Se (Table 4 and Fig. 4 ) accompanied by (additionally tested) negative association with blood and plasma Se (data not presented). From the present study, it is impossible to speculate whether the supposed co-elimination of U∑As M and U-Se is related to special As-Se complexes (Gailer et al., 2002; La Porte, 2011) or to the coincidental use of the same transport pathways. AQPs are generalized metalloid channels (Mukhopadhyay et al., 2014) . Therefore, our results could indicate the potential role of AQPs (AQP9) in the cellular transport of Se, as previously hypothesised by Misra et al. (2012) in an in vitro study on rainbow trout hepatocytes and enterocytes and by Geng et al. (2017) when studying monomethylselenic acid and selenite in Xenopus laevis oocyte after the overexpression of human AQP9. 3.4.2.4 . SELENOP. SELENOP is the major plasma selenoprotein with anti-oxidative, transport, and metal-binding functions (Burk and Hill, 2015) . It exists in two isoforms of 60 and 50 kDa, and the latter is considered to lack the cysteine-and selenocysteine-rich C-terminal domain (Burk and Hill, 2015; Méplan et al., 2009) . Frequently reported SELENOP SNPs rs7579 and rs3877899 were previously studied mostly in relation to the proportions of SELENOP isoforms and Se levels in blood/plasma (Mao et al., 2016; Méplan et al., 2009) . However, ours is the first study to investigate the relation with As metabolism. We did not find any significant associations with Se levels (in urine, blood or plasma). For As, the only significant association was observed for rs7579 in non-pregnant women, specifically, a negative one with PMI (Table 4 and Fig. 4) .
SNP rs7579 was previously reported to be associated with higher proportion of the 60 kDa SELENOP isoform containing the cysteine-and histidine-rich domain that is supposed to be involved in the metal(loid)s binding function (Burk and Hill, 2015; Méplan et al., 2009 ). According to preliminary results from a study on APL patients treated with As 3 O 2 , a part of AsIII can be bound on SELENOP (Falnoga et al., 2010) , especially on the longer 60 kDa isoform (unpublished data Falnoga and Stibilj) . Therefore, we could probably speculate on the higher amount of SELENOP-bounded As with lower accessibility for methylation among the carriers of the minor allele in the present study. This could explain their lower primary methylation rate. *Data with (marginal) significance (p < 0.1); bolded are significant differences in the multivariable linear regression models after adjustment for age, pre-pregnancy BMI, child sex, ever smoking, parity, plasma Se and blood As in pregnant women; age, BMI, ever smoking, plasma Se and blood As in non-pregnant women; and gender, height, weight, smoking parents, plasma Se and blood As in children. U-∑As, sum of AsIII, MMA, and DMA; PMI, primary methylation index (MMA/AsIII); SMI, secondary methylation index (DMA/MMA); TMI, total methylation index ((MMA+DMA)/AsIII).
INMT.
INMT is a transmethylation enzyme that has been recently recognized to play an important role in Se elimination (Kuehnelt et al., 2015) . Specifically, its gene polymorphism rs6970396 was shown to be a major predictor of the production of the common Se metabolite trimethylselenonium ion (TMSe). Carriers of the minor allele were identified as TMSe producers (high TMSe% in urine) and those of the common allele, as its non-producers (low TMSe % in urine) (Kuehnelt et al., 2015; Skröder et al., 2018) . Low INMT minor allele frequencies were found for populations with known historical exposure to high iAs through water intake, with 1.5% for Argentinian Andean and 5% for Peruvian populations (Kuehnelt et al., 2015) . In combination with high frequencies of 'protective' AS3MT haplotype(s) (Engström et al., 2011) , low frequencies of INMT are assumed to be beneficial for As detoxification. In the present study, frequencies of SNP rs6970396 were between 10% and 13% and were significantly associated with higher urine concentrations of As methylated metabolites and/or Se in bivariate comparisons of all groups (Table 4) . After adjustment, the associations for MMA, DMA, and Se were confirmed only in non-pregnant women (Table 4 and Fig. 4) .
In a study on Bangladeshi pregnant women (n = 226; GW 8), Skröder et al. (2018) reported data that are in accordance with our positive associations for U-Se and absent associations with As methylation efficiency, although their observations were not assessed with adjustment for confounders.
For better interpretation of our results, data on TMSe levels in urine are needed.
3.4.2.6. MT2A. Metallothioneins (MTs) are inducible low-molecular (6-7 kDa) cysteine-rich (20) metal-binding proteins with 11 functional (sub)isoforms with various functions (Krężel and Maret, 2017; Ling et al., 2016; Ruttkay-Nedecky et al., 2013; Shen et al., 2013) ; isoform MT2A is the most widely expressed one. MT2A and its genetic polymorphisms were frequently studied in relation to metal(loid) levels and diseases owing to their various functions including metalion homeostasis (Cu and Zn) redox and anti-oxidative functions and Fig. 4 . Significant associations (presented as β coefficients, p < 0.05) of SNPs' minor alleles and AS3MT 'protective' haplotype with As methylation parameters (AsIII%, MMA%, DMA%, PMI, SMI, and TMI) and urine elimination parameters of As and Se (AsIII, MMA, DMA, U-∑As M and U-Se; ng/mL SG ) from multiple regression models for pregnant women (adjusted for: age, pre-pregnancy BMI, child sex, ever smoking, parity, P-Se and B-As), non-pregnant women (adjusted for: age, BMI, ever smoking, P-Se and B-As) and children (adjusted for: gender, height, weight, smoking parents, P-Se and B-A).
Table 5
Comparison of observed associations (multiple regression models) between AS3MT SNPs and As methylation in present study with those in previous studies exposed to low and high iAs.
SNP
Allele PRESENT STUDY LITERATURE STUDY metal(loid)s detoxification (Cd, Hg, Pb, and As). However, only a few studies have investigated rs28366003 polymorphisms in MT2A in relation to As (Akyüzlü et al., 2013; Eom et al., 2016; González-Martínez et al., 2018) . In the present study, we observed its influence on As concentration. Significant associations of SNP were observed in all study groups, but with different As parameters (Table 4 and Fig. 4) . Adjusting for confounders resulted in significant associations of MT2A with higher AsIII urine concentrations and (consequently) lower As methylation capacity in pregnant and non-pregnant women (Table 4 and Fig. 4) . Akyüzlü et al. (2013) observed a similar influence on As levels in urine in a study on individuals who are occupationally exposed to As (n = 95, arithmetic mean: B-As, 21.2 ng/mL and U-As, 6.4 ng/mL). By contrast, Gonzales-Martinez et al. (2018) found no significant association in a recent study on a Columbian population (n = 101, median UAs M : 5.9 ng/g crea).
The rs28366003 minor allele was reported to be significantly associated with lower MT2A gene expression (Krześlak et al., 2013; Starska et al., 2014) . Therefore, one can hypothesise that lower MT2A expression could lead to reduced transport of MT2A-bound As into the liver and, consequently, lower amount of methylated As and higher elimination of GSH-conjugated AsIII into urine. However, the interpretation of the observed association in the present study is problematic owing to the very low number of individuals having rs28366003 minor allele (Table 3) , especially among children, resulting in low statistical power (n = 18, 16, and 7 in pregnant women, non-pregnant women, and children, respectively).
Confounders and R
2 values of models. All associations were tested using a set of various confounders whose combination was specific for each study group. As in blood (representing general As intake), plasma Se, age, BMI, and ever smoking status were assessed for pregnant and non-pregnant women, and parity and child sex were additionally assessed for pregnant women only. As in blood, plasma Se, gender, weight, height, and smoking of parents was assessed for children. The selection of confounders is explained in details in the material and methods section.
Only a few of the tested confounders modified the effects of gene polymorphisms on the studied As and Se urine parameters (Table 7) . Among all, the strongest influence was observed for plasma Se among pregnant and non-pregnant women (β ± 0.5-0.9). In pregnant women, it was inversely associated with urine AsIII concentration and AsIII% and, correspondingly, positively associated with PMI and TMI indexes. Such results may roughly indicate the possible increase of As hepatobiliary elimination in the form of the proposed As-Se-GSH complex (Roggenbeck et al., 2016) . Among non-pregnant women, plasma Se was positively associated with As methylation efficiency, as most evidently seen from the SMI parameter. Pilsner et al. (2011) found similar trends for associations between plasma Se and As metabolite percentages in blood. They suggested that Se adequacy may be involved in the mechanism by which it can indirectly facilitate the methylation of MMA to DMA (Pilsner et al., 2011) .
Other confounders with noticeable influence in order based on the strength of their effect were ever smoking and parity among pregnant women, gender among children, and blood As in all study groups and pre-pregnancy BMI among pregnant women. Associations of ever smoking with higher urine AsIII levels and percentages and poorer methylation confirm the observations of previous studies (Shen et al., 2016; Tseng, 2009) . Parity (1-3 deliveries) associated with more efficient methylation can be explained by improved placental functions with number of deliveries (Prior et al., 2014) . Arsenic methylation also occurs in the placenta (Fei et al., 2013; Winterbottom et al., 2017) . Among children, girls show higher AsIII urine concentration but poorer methylation compared to boys; this finding differs from that of some previous studies that reported no gender influence on As methylation in children (Recio-Vega et al., 2016; Skröder Löveborn et al., 2016; Torres- Table 7 Ranges of selected β coefficients (min/max) Sánchez et al., 2016). In general, blood As was associated with more efficient As methylation, as reflected mostly by the higher urine DMA concentrations and lower MMA%. These results are in accordance with the known fact that at low levels, iAs can increase AS3MT activity, whereas at higher levels, the enzyme is inhibited (Fowler et al., 2015) . Pre-pregnancy BMI among pregnant women was weakly associated with lower levels of DMA and ∑As M . SNPs and confounders explained up to 18% of the variation in As methylation parameters in all study groups (Table 7) . A similar percentage was reported by Lindberg et al. (2007) in a comparable study on a Central European population. In the case of As urine parameters, the percentage of variation explained was below 28% for pregnant women and below 12% for non-pregnant women and their children. Less than 10% of the variation in Se urine concentration was explained ( Table 7) .
Conclusions
Polymorphisms of various genes showed distinct impacts on As and Se parameters in study groups with estimated low iAs exposure.
In non-pregnant women we confirmed the positive influence of SNPs (and 'protective' haplotype) of AS3MT on iAs methylation efficiency but without a significant change in the urine concentration of metabolites. At the same time, various influences were observed for SNPs of genes which can affect As metabolites transport pathways (cellular uptake or efflux, reuptake in kidney cells). They were associated with increased urine concentration of methylated As metabolites (AQP9 rs2414539 and INMT rs6970396) or AsIII only (MT2A rs28366003). Consequently, they indirectly influenced methylation capacity in a positive (AQP9) or negative (MT2A) way through various mechanisms, as discussed above.
Among pregnant women and children, the associations were scarce. A few of them were similar to those observed among non-pregnant women: SNP4 of AS3MT (rs3740390) in children and MT2A in pregnant women. The influence of AQP4 (rs9951307) was observed exclusively among pregnant women. Carriers of the minor allele had higher urine AsIII (percentages and concentration) and diminished primary and total methylation index.
Selenium levels were used in two ways: as a confounder (plasma Se) and as observing parameter (urine Se). Among confounders it showed a stronger influence on arsenic parameters (like decrease of AsIII%). Its urine concentrations were positively affected by INMT or AQP9 SNPs; both effects could be linked to the amounts of the Se metabolite TMSe, which should be analysed in the next step for the proper interpretation of its possible co-excretion with As metabolites.
The assessment showed that at low levels of iAs exposure, the impact of physiological states (pregnancy or childhood) obviously dominated over the genetic effect on methylation (AS3MT) or emphasised the genetic effects on As (AsIII) levels (APQ4). The novel associations found for AQPs with As and Se parameters are intriguing and need further study. In the kidney, a whole set of AQPs is active and they can even change their function(s) during pregnancy (Nielsen et al., 2002) . Therefore, it is needed to check SNPs for all of them as well as their interactive effects.
